Tag: MDPI

Posted on

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   Asthma
Interventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  Advair
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Condition:   Persistent Asthma
Interventions:   Drug: Fluticasone propionate Multidose Dry Powder Inhaler (Fp MDPI);   Drug: Fluticasone propionate /salmeterol MDPI (FS MDPI);   Drug: Fluticasone propionate HFA Inhalation Aerosol;   Drug: Fluticasone propionate/salmeterol dry powder formulation
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified June 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days